DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,010
-10 (-0.07%)
At close: Apr 28, 2026
-8.81%
Market Cap 262.92B
Revenue (ttm) 143.06B
Net Income (ttm) 1.65B
Shares Out 17.52M
EPS (ttm) 94.00
PE Ratio 159.68
Forward PE n/a
Dividend 150.00 (1.00%)
Ex-Dividend Date Dec 29, 2025
Volume 53,181
Average Volume 58,442
Open 15,030
Previous Close 15,020
Day's Range 14,790 - 15,100
52-Week Range 12,650 - 24,900
Beta -0.11
RSI 53.48
Earnings Date May 14, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

In 2025, DAE HWA Pharmaceutical's revenue was 143.06 billion, a decrease of -4.25% compared to the previous year's 149.41 billion. Earnings were 1.65 billion, an increase of 211.15%.

Financial Statements

News

There is no news available yet.